G

GL Pharm Tech Corp
KOSDAQ:204840

Watchlist Manager
GL Pharm Tech Corp
KOSDAQ:204840
Watchlist
Price: 1 128 KRW -3.01% Market Closed
Market Cap: 87.5B KRW

Intrinsic Value

The intrinsic value of one GL Pharm Tech Corp stock under the Base Case scenario is 744.42 KRW. Compared to the current market price of 1 128 KRW, GL Pharm Tech Corp is Overvalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
744.42 KRW
Overvaluation 34%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
GL Pharm Tech Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about GL Pharm Tech Corp?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GL Pharm Tech Corp valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for GL Pharm Tech Corp.

Explain Valuation
Compare GL Pharm Tech Corp to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GL Pharm Tech Corp?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
GL Pharm Tech Corp

Current Assets 19B
Cash & Short-Term Investments 1.7B
Receivables 6.6B
Other Current Assets 10.7B
Non-Current Assets 24.7B
Long-Term Investments 3.1B
PP&E 19B
Intangibles 1.5B
Other Non-Current Assets 1.1B
Current Liabilities 14.3B
Accounts Payable 2.1B
Short-Term Debt 3.9B
Other Current Liabilities 8.3B
Non-Current Liabilities 9.6B
Long-Term Debt 6.7B
Other Non-Current Liabilities 2.9B
Efficiency

Free Cash Flow Analysis
GL Pharm Tech Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
GL Pharm Tech Corp

Revenue
29.4B KRW
Cost of Revenue
-16.2B KRW
Gross Profit
13.2B KRW
Operating Expenses
-12.7B KRW
Operating Income
491.1m KRW
Other Expenses
-434.1m KRW
Net Income
57m KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

GL Pharm Tech Corp's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Operating Margin is Increasing
Healthy Gross Margin
40/100
Profitability
Score

GL Pharm Tech Corp's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

GL Pharm Tech Corp's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
40/100
Solvency
Score

GL Pharm Tech Corp's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
GL Pharm Tech Corp

There are no price targets for GL Pharm Tech Corp.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

GL Pharm Tech Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for GL Pharm Tech Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one GL Pharm Tech Corp stock?

The intrinsic value of one GL Pharm Tech Corp stock under the Base Case scenario is 744.42 KRW.

Is GL Pharm Tech Corp stock undervalued or overvalued?

Compared to the current market price of 1 128 KRW, GL Pharm Tech Corp is Overvalued by 34%.

Back to Top